[Pleural effusion as a manifestation of ovarian hyperstimulation syndrome, after treatment with triptoreline for uterus myomata].
Andreu
A L
AL
Chiner
E
E
Gómez Merino
E
E
Signes-Costa
J
J
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy; D008875:Middle Aged; D016471:Ovarian Hyperstimulation Syndrome / Q000139:chemically induced*; D010996:Pleural Effusion / Q000139:chemically induced*; D017329:Triptorelin Pamoate / Q000009:adverse effects*; D014594:Uterine Neoplasms / Q000188:drug therapy
D018931:Antineoplastic Agents, Hormonal; D017329:Triptorelin Pamoate